Abstract
Indomethacin is a non-narcotic and non-steroidal anti-inflammatory drug used in the treatment of various inflammatory diseases such as rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis. In neonates, it is also used for induction of closure of patent ductus arteriosus (PDA). Its mechanism of action is believed to be through the inhibition of cyclooxygenase. Due to narrow therapeutic window and number of side effects, it’s monitoring, particularly in neonates, is recommended. In the gas chromatography method described here, the drug is extracted from serum or plasma using methylene chloride and phosphate buffer (pH 6). The methylene chloride phase containing drug is separated and dried under stream of nitrogen. The drug is derivatized using Bis-(Trimethylsilyl)trifluoroacetamide (BSTFA) with 1% TMCS (trimethylchlorosilane). The derivatized drug is analyzed using gas chromatography- mass spectrometry. Quantitation of the drug in a sample is achieved by comparing responses of the unknown sample to the responses of the calibrators using selected ion monitoring. Meclofenamic acid is used as an internal standard.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Lee, K.S. (2008) Indomethacin therapy for patent ductus arteriosus in premature infants. Pediatr Cardiol, 29, 873–5.
O’Donovan, D.J., Fernandes, C.J., Nguyen, N.Y., Adams, K. and Adams, J.M. (2004) Indomethacin therapy for patent ductus arteriosus in premature infants: efficacy of a dosing strategy based on a second-dose peak plasma indomethacin level and estimated plasma indomethacin levels. Am J Perinatol, 21, 191–7.
Takami, T., Yoda, H., Kawakami, T., Yamamura, H., Nakanishi, T., Nakazawa, M., Takei, Y., Miyajima, T. and Hoshika, A. (2007) Usefulness of indomethacin for patent ductus arteriosus in full-term infants. Pediatr Cardiol, 28, 46–50.
Broussard, L.A., McCudden, C.R. and Garg, U. (2007) Therapeutic drug monitoring of analgesics in “Therapeutic Drug Monitoring Data”. Eds. Hammett-Stabler C.A. and Dasgupta A., AACC Press, Washington DC, pp. 193–6.
Fenton, J. (1998) Indomethacin in “The Laboratory and the Poisoned Patient: A Guide for Interpreting Laboratory Data”, AACC Press, Washington DC, pp. 193–5.
Al Za’abi, M.A., Dehghanzadeh, G.H., Norris, R.L. and Charles, B.G. (2006) A rapid and sensitive microscale HPLC method for the determination of indomethacin in plasma of premature neonates with patent ductus arteriousus. J Chromatogr B Analyt Technol Biomed Life Sci, 830, 364–7.
Sato, J., Amizuka, T., Niida, Y., Umetsu, M. and Ito, K. (1997) Simple, rapid and sensitive method for the determination of indomethacin in plasma by high-performance liquid chromatography with ultraviolet detection. J Chromatogr B Biomed Sci Appl, 692, 241–4.
Singh, A.K., Jang, Y., Mishra, U. and Granley, K. (1991) Simultaneous analysis of flunixin, naproxen, ethacrynic acid, indomethacin, phenylbutazone, mefenamic acid and thiosalicylic acid in plasma and urine by high-performance liquid chromatography and gas chromatography-mass spectrometry. J Chromatogr, 568, 351-61.
Taylor, P.J., Jones, C.E., Dodds, H.M., Hogan, N.S. and Johnson, A.G. (1998) Plasma indomethacin assay using high-performance liquid chromatography-electrospray-tandem mass spectrometry: application to therapeutic drug monitoring and pharmacokinetic studies. Ther Drug Monit, 20, 691–6.
Vree, T.B., van den Biggelaar-Martea, M. and Verwey-van Wissen, C.P. (1993) Determination of indomethacin, its metabolites and their glucuronides in human plasma and urine by means of direct gradient high-performance liquid chromatographic analysis. Preliminary pharmacokinetics and effect of probenecid. J Chromatogr, 616, 271–82.
Dawson, M., Smith, M.D. and McGee, C.M. (1990) Gas chromatography/negative ion chemical ionization/tandem mass spectrometric quantification of indomethacin in plasma and synovial fluid. Biomed Environ Mass Spectrom, 19, 453–8.
Nishioka, R., Harimoto, T., Umeda, I., Yamamoto, S. and Oi, N. (1990) Improved procedure for determination of indomethacin in plasma by capillary gas chromatography after solid-phase extraction. J Chromatogr, 526, 210–4.
Acknowledgment
We acknowledge the help of David Scott in preparing the figures.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Thomas, S., Sutton, A., Garg, U. (2010). Quantitation of Indomethacin in Serum and Plasma Using Gas Chromatography-Mass Spectrometry (GC-MS). In: Garg, U., Hammett-Stabler, C. (eds) Clinical Applications of Mass Spectrometry. Methods in Molecular Biology, vol 603. Humana Press. https://doi.org/10.1007/978-1-60761-459-3_28
Download citation
DOI: https://doi.org/10.1007/978-1-60761-459-3_28
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60761-458-6
Online ISBN: 978-1-60761-459-3
eBook Packages: Springer Protocols